Platinum-resistant Recurrent Ovarian Cancer

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS research · 2026-03-27
Clinical Trial Update: Efficacy and Safety of CapsuleX Combined With Cisplatin in Platinum-Resistant Recurrent Ovarian Cancer: A Single-Arm Prospective Clinical Study [NA]
This clinical trial update states that CapsuleX combined with cisplatin for platinum-resistant recurrent ovarian cancer is currently recruit…
CLINICAL_TRIALS research · 2026-01-02
Clinical Trial Update: Prospective, Multicenter, Single-Arm, Phase Ⅱ Clinical Study on the Efficacy and Safety of Sacituzumab Tirumotecan Combined With Bevacizumab in Platinum-Resistant Recurrent Ovarian Cancer [Phase 2]
A prospective, multicenter, single-arm Phase 2 trial is evaluating sacituzumab tirumotecan plus bevacizumab for platinum-resistant recurrent…